Characterization of novel promoter and enhancer elements of the mouse homologue of the Dent disease gene, Clcn5, implicated in X-linked hereditary nephrolithiasis

被引:9
作者
Tanaka, K
Fisher, SE
Craig, IW [1 ]
机构
[1] Univ Oxford, Dept Biochem, Oxford OX1 3QU, England
[2] Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford OX3 7BN, England
[3] Teikyo Univ, Sch Med, Itabashi Ku, Tokyo 173, Japan
[4] Inst Psychiat, London SE5, England
基金
英国惠康基金;
关键词
D O I
10.1006/geno.1999.5839
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
The murine homologue of the human chloride channel gene, CLCN5, defects in which are responsible for Dent disease, has been cloned and characterized. We isolated the entire coding region of mouse Clcn5 cDNA and similar to 45 kb of genomic sequence embracing the gene. To study its transcriptional control, the 5' upstream sequences of the mouse Clcn5 gene were cloned into a luciferase reporter vector. Deletion analysis of 1.5 kb of the 5' flanking sequence defined an active promoter region within 128 bp of the putative transcription start site, which is associated with a TATA motif but lacks a CAAT consensus. Within this sequence, there is a motif with homology to a purine-rich sequence responsible for the kidney-specific promoter activity of the rat CLC-K1 gene, another member of the chlomide-channel gene family expressed in kidney. An enhancer element that confers a 10- to 20-fold increase in the promoter activity of the mouse Clcn5 gene was found within the first intron, The organization of the human CLCN5 and mouse Clcn5 gene structures is highly conserved, and the sequence of the murine protein is 98% similar to that of human, with its highest expression seen in the kidney. This study thus provides the first identification of the transcriptional control region of, and the basis for an understanding of the regulatory mechanism that controls, this kidney-specific, chloride-channel gene. (C) 1999 Academic Press.
引用
收藏
页码:281 / 292
页数:12
相关论文
共 57 条
[1]  
Aguanno A, 1996, J BIOL CHEM, V271, P4528
[2]   CELL-SPECIFIC EXPRESSION OF CYTOSOLIC PHOSPHOENOLPYRUVATE CARBOXYKINASE IN TRANSGENIC MICE [J].
BEALE, EG ;
CLOUTHIER, DE ;
HAMMER, RE .
FASEB JOURNAL, 1992, 6 (15) :3330-3337
[3]   WEIGHT MATRIX DESCRIPTIONS OF 4 EUKARYOTIC RNA POLYMERASE-II PROMOTER ELEMENTS DERIVED FROM 502 UNRELATED PROMOTER SEQUENCES [J].
BUCHER, P .
JOURNAL OF MOLECULAR BIOLOGY, 1990, 212 (04) :563-578
[4]   Involvement of HNF-1 in the regulation of phosphoenolpyruvate carboxykinase gene expression in the kidney [J].
Cassuto, H ;
Olswang, Y ;
Livoff, AF ;
Nechushtan, H ;
Hanson, RW ;
Reshef, L .
FEBS LETTERS, 1997, 412 (03) :597-602
[5]  
CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1016/0003-2697(87)90021-2
[6]   GENOMIC SEQUENCING [J].
CHURCH, GM ;
GILBERT, W .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA-BIOLOGICAL SCIENCES, 1984, 81 (07) :1991-1995
[7]  
COHEN D, 1991, J BIOL CHEM, V266, P2239
[8]   LFB3, A HETERODIMER-FORMING HOMEOPROTEIN OF THE LFB1 FAMILY, IS EXPRESSED IN SPECIALIZED EPITHELIA [J].
DESIMONE, V ;
DEMAGISTRIS, L ;
LAZZARO, D ;
GERSTNER, J ;
MONACI, P ;
NICOSIA, A ;
CORTESE, R .
EMBO JOURNAL, 1991, 10 (06) :1435-1443
[9]   A COMPREHENSIVE SET OF SEQUENCE-ANALYSIS PROGRAMS FOR THE VAX [J].
DEVEREUX, J ;
HAEBERLI, P ;
SMITHIES, O .
NUCLEIC ACIDS RESEARCH, 1984, 12 (01) :387-395
[10]   A TECHNIQUE FOR RADIOLABELING DNA RESTRICTION ENDONUCLEASE FRAGMENTS TO HIGH SPECIFIC ACTIVITY [J].
FEINBERG, AP ;
VOGELSTEIN, B .
ANALYTICAL BIOCHEMISTRY, 1983, 132 (01) :6-13